Executive Committee

Professor Vivekanand Jha is the President of the International Society of Nephrology. He also covers the role of Executive Director at The George Institute for Global Health, India. Prof. Jha is recognized as a global expert on kidney disease and focuses on emerging public health threats globally and in India.

He currently leads research projects operating in more than 20 countries. He is particularly interested in using multi-disciplinary approaches and innovations to address the system level health and economic challenge posed to humanity by non-communicable diseases.

He has published over 320 peer reviewed papers, many in the most prestigious journal in the world and over 40 book chapters. He has held leadership positions in many organizations. He is a member of Task Forces and Scientific Advisory Committees of the Department of Science and Technology of Government of India, an Advisor to the WHO, has been on Editorial Boards of major journals and has been Section Editor of the Oxford Textbook of Clinical Nephrology.

Professor Agnes Borge Fogo completed her medical and pathology training at Vanderbilt University, Nashville, TN, USA. Her main research interests are focused on progression of chronic kidney disease and crosstalk between tubules and glomeruli, funded by the NIH and other sources.

AM, MD, MBBS, FRACP

Professor of Medicine, University of Sydney; Director of Nephrology and Dialysis of Western Sydney Renal Service; Director of Renal Failure Laboratory in Centre for Transplantation and Renal Research, Westmead Institute for Medical Research.

Chair of ISN Programs, immediate Past-President of ISN, Past-President of APSN and ANZSN. Some recent awards include Member of Order of Australia (2019), Richard Yu Award of Hong Kong Society of Nephrology (2017), Distinguished Professorial Award (Sydney University, 2016), Associé Etranger French Academy of Medicine (2016), Medical Staff Council Award for contributions to Westmead Hospital (2016) and Priscilla Kincaid-Smith Medal for outstanding clinical and scientific achievement in research into treatment of diseases of kidney & urinary tract (2012).

Published more than 350 papers, and delivered more than 250 invited national and international presentations. Main clinical and research interests include progressive CKD and dialysis, and laboratory interests include pathogenesis of and novel therapies for progressive CKD.

Dr Adrian Liew is a Senior Consultant Nephrologist and Director of the The Kidney & Transplant Practice at Mount Elizabeth Novena Hospital in Singapore. Besides being an elected member of the Executive Committee and Council of the International Society of Nephrology (ISN), his other responsibilities in ISN include being the  Chair of the ISN Oceania-Southeast Asia Regional Board and the ISN Renal Disaster Preparedness Working Group; and as a member of the ISN Dialysis Committee and ISN CME Committee.

He is also an elected Executive and Honorary Secretary of the International Society for Peritoneal Dialysis (ISPD) and a member of the Asia-Pacific Society of Nephrology (APSN) CME Committee. In addition, he is an appointed member of the working groups for the KDIGO Guideline on Glomerular Disease 2020 Update, KDIGO Guideline on Diabetes Management in Chronic Kidney Disease and ISPD Practice Recommendations on Prescribing High-Quality Goal-Directed Peritoneal Dialysis, while he chairs the working group for the APSN Guideline on Diabetic Kidney Disease 2020. For his contributions to the development of peritoneal dialysis internationally, Dr Liew was presented the John Maher award by ISPD in 2020.

Dr Elena Zakharova is a head of Nephrology Department of Moscow City Clinical Hospital n.a. S.P. Botkin, associate Professor of Nephrology in the Russian Medical Academy of Continuous Professional Education, and in the Moscow State University of Medicine and Dentistry.

She was born in Moscow, studied General Medicine in the Institute of Medicine and Dentistry, graduated residency in nephrology, and defended her PhD Thesis “Prognostic Factors of Outcomes in Systemic Lupus Erythematosus and Systemic Vasculitis with Kidney Involvement”. Her current research interests include diagnostics and treatment of idiopathic glomerulonephritis, systemic diseases, thrombotic microangiopathies, monoclonal gammopathies of renal significance, and pregnancy-related kidney disorders; she authored and co-authored 165 publications in Russian and International journals. Dr Zakharova is currently the Russian Dialysis Society president.

Elena Zakharova is an active member of the ISN since 2006; she is currently the ISN ExCom and Council member, EAP Committee chair, and Regional Board for NIS&Russia co-chair.

MB ChB (Natal); MRCP (UK); FRCP (London); PhD (Natal); FCP(SA)

Currently Emeritus Professor of Medicine and chair of Research and Graduate Studies, and Mentorship Committees of School of Clinical Medicine at University of Witwatersrand(Wits), Johannesburg. Previously, Academic Head, Department of Internal Medicine (2009-2013) and Division of Nephrology (2001-2014) at Wits. Best Postgraduate Supervisor award, Wits Faculty of Health Sciences, 2017.

She has been president of the SA Renal Society (1994-1997; 2012-2015), and president of the SA Transplantation Society (1991-1993) and chaired the SA Ministerial Advisory Committee for Transplantation (2017-2019).

She chaired the ISN Africa Regional Committee (2000-2007), Educational Ambassador Program (2009-2015); served on ISN Council (2005-2011) and Executive Committee (2007-2009); ISPD Council (2010-2014) and chaired ISPD Fellowships and Awards Committee (2014-2018); member of KDIGO Executive Committee (2013-2015) and co-chaired the DICG Professional Societies Working Group (2009-2013).

She chaired the ISN Nominating Committee (2018-2019) and is a member of the ISN Executive Committee (2019-2021).

Recipient of ISN Roscoe Robinson award, 2009.

MBChB (Glasgow), MSc (Aberdeen), MD (Aberdeen), FRCP (London).

Having graduated from the University of Glasgow in 1993, Fergus went on to obtain a Masters in Health Services and Public Health Research and then an MD in the Cost-effectiveness of Dialysis in Europe from the University of Aberdeen. He became a Consultant Nephrologist in Bristol in 2005 and was Medical Director of the UK Renal Registry from 2013-2019.

Now based at the University of Bristol and North Bristol NHS Trust, his research interests include the epidemiology of kidney disease, particularly around equity of access to treatment, and using embedded qualitative research and routine healthcare data to improve the efficiency of clinical trials. He is chief investigator of two ongoing NIHR HTA-funded trials, Prepare for Kidney Care and the High-volume HDF vs High-flux HD Registry Trial.

He chairs the SharE-RR Steering Committee for ISN (www.theisn.org/advocacy/share-rr) and is a member of the ISN Executive Committee.

Dr Luyckx obtained her MD degree (MBBCh) from the University of the Witwatersrand in South Africa, an MSc in Public Health from the London School of Hygiene and Tropical Medicine and a PhD in Biomedical Ethics from University of Zurich. She trained in nephrology at Massachusetts General Hospital and Brigham and Women’s Hospital, Harvard Medical School where she remains an associate lecturer in the Renal Division.

She has worked clinically across a broad range of health systems. Dr Luyckx advocates strongly for patients with kidney disease, working on ethical and practical challenges of managing kidney disease in resource-limited environments, and is passionate about mentoring diverse leaders in nephrology. Membership of the ISN has provided a strong network from which to pursue these goals and to learn from many global leaders. She has served as a consultant for WHO in ethics and is a member of the Swiss Central Ethics Committee.

Charu Malik has over 15 years of experience in the non-profit sector, the majority of which have been with professional healthcare societies.

She comes to the ISN from the Association for Professionals in Infection Control and Epidemiology (APIC), where she was the Vice President for Education, Research, and Special Projects.

Prior to APIC, she was the Executive Director for the World Allergy Organization, a global federation of almost 100 national and regional societies. In this capacity, she led the conceptualization, development, and execution of several innovative international partnership ventures, including disease-specific multi-partner, multi-sponsor, and multi-year research and educational initiatives.